The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Open accessAbstract
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, DNA damage induces the accumulation of BRCA-FA proteins in nuclear foci [33].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [33]
In the citing paper
“Since BRCA1 interacts with FancD2 and mediates FancD2 foci formation after treatment with MMC (Bunting et al., 2012; Garcia-Higuera et al., 2001; Vandenberg et al., 2003)”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Garcia-Higuera et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 1,151
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S. L., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,011
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 919
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Cited by
Sorted by citations
Items 701–800 of 1,000
Ouyang, Y., Kwon, Y. T., An, J. Y., Eller, D., Tsai, S.-C., Diaz-Perez, S. V., Troke, J. J., Teitell, M. A., & Marahrens, Y. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.12.016 · Cited by 28
Milsom, M. D., Schiedlmeier, B., Bailey, J., Kim, M., Li, D., Jansen, M., Ali, A. M., Kirby, M., Baum, C., Fairbairn, L., et al. (2009) · Blood · doi:10.1182/blood-2008-09-180224 · Cited by 26
A small ubiquitin binding domain inhibits ubiquitin-dependent protein recruitment to DNA repair foci
Helchowski, C. M., Skow, L., Roberts, K. H., Chute, C. L., & Canman, C. E. (2013) · Cell Cycle · doi:10.4161/cc.26640 · Cited by 28
Borriello, A., Locasciulli, A., Bianco, A. M., Criscuolo, M., Conti, V., Grammatico, P., Cappellacci, S., Zatterale, A., Morgese, F., Cucciolla, V., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404468 · Cited by 27
Fanconi anemia pathway defects in inherited and sporadic cancers.
Chen, H., Zhang, S., & Wu, Z. (2014) · PubMed Central · doi:10.3978/j.issn.2224-4336.2014.07.05 · Cited by 30
Molecular Pathogenesis of Fanconi Anemia
Collins, N. B., & Kupfer, G. M. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05108 · Cited by 26
Yan, Y., Black, C. P., Cao, P. T., Haferbier, J. L., Kolb, R. H., Spieker, R. S., Ristow, A. M., & Cowan, K. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5818 · Cited by 26
3R coordination by Fanconi anemia proteins
Macé‐Aimé, G., Bogliolo, M., Guervilly, J.-H., du Villard, J.-A. D., & Rosselli, F. (2005) · Biochimie · doi:10.1016/j.biochi.2005.05.003 · Cited by 26
Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9
Nakanishi, K., Moran, A., Hays, T., Kuang, Y., Fox, E., Garneau, D., Oca, R. M. D., Grompe, M., & D’Andrea, A. D. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00663-4 · Cited by 26
Self-citationA germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsPreprint
Wilkes, D. C., Sailer, V., Xue, H., Cheng, H., Collins, C. C., Gleave, M. E., Wang, Y. Z., Demichelis, F., Beltran, H., Rubin, M. A., et al. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001487 · Cited by 26
Towards a Molecular Understanding of the Fanconi Anemia Core Complex
Hodson, C., & Walden, H. (2012) · Anemia · doi:10.1155/2012/926787 · Cited by 27
High Glucose Increases DNA Damage and Elevates the Expression of Multiple DDR Genes
Rahmoon, M. A., Elghaish, R. A., Ibrahim, A. A., Alaswad, Z., Gad, M. Z., El‐Khamisy, S. F., & Elserafy, M. (2023) · Genes · doi:10.3390/genes14010144 · Cited by 25
FANCD2 influences replication fork processes and genome stability in response to clustered DSBs
Zhu, J., Su, F., Mukherjee, S., Mori, E., Hu, B., & Asaithamby, A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1036210 · Cited by 25
Huard, C., Tremblay, C. S., Helsper, K., Delisle, M., Schindler, D., Lévesque, G., & Carreau, M. (2013) · Blood · doi:10.1182/blood-2012-02-408997 · Cited by 25
Rı́o, P., Agirre, X., Gárate, L., Baños, R., Alvarez, L. A., José‐Eneriz, E. S., Badell, I., Casado, J. A., Garin, M. I., Prósper, F., et al. (2012) · Blood · doi:10.1182/blood-2011-01-331017 · Cited by 25
Kuhnert, V. M., Kachnic, L. A., Li, L., Purschke, M., Gheorghiu, L., Lee, R., Held, K. D., & Willers, H. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902883810 · Cited by 25
Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks
Mason, J. M., & Sekiguchi, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr153 · Cited by 25
O’Connell, M. J. (2010) · Journal of Molecular Evolution · doi:10.1007/s00239-010-9399-y · Cited by 25
Jiang, J., Bellani, M. A., Li, L., Wang, P., Seidman, M. M., & Wang, Y. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01135 · Cited by 25
Eccles, L. J., Bell, A., & Powell, S. N. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.02.003 · Cited by 25
BRCA-FA Pathway as a Target for Anti-Tumor Drugs
Flynn, R. L., Gupta, R., Brosh, R. M., & Cantor, S. B. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784220285 · Cited by 25
Duan, W., Gao, L., Zhao, W., Leon, M. E., Sadée, W., Webb, A., Resnick, K. E., Wu, X., Ramaswamy, B., Cohn, D. E., et al. (2012) · Translational research · doi:10.1016/j.trsl.2012.09.003 · Cited by 24
Vuono, E. A., Mukherjee, A., Vierra, D. A., Adroved, M. M., Hodson, C., Deans, A. J., & Howlett, N. G. (2016) · Scientific Reports · doi:10.1038/srep36439 · Cited by 24
Zhu, B., Yan, K., Li, L., Lin, M., Zhang, S., He, Q., Zheng, D., Yang, H., & Shao, G. (2014) · Oncogene · doi:10.1038/onc.2014.229 · Cited by 25
Jun, D. W., Hwang, M., Kim, H. J., Hwang, S. K., Kim, S., & Lee, C. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075905 · Cited by 24
Ozawa, H., Iwatsuki, M., Mimori, K., Sato, T., Johansson, F., Toh, H., Watanabe, M., & Mori, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1002-7 · Cited by 24
A major switch for the Fanconi anemia DNA damage–response pathway
Wang, W. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1108-1128 · Cited by 24
Biomarkers and Mechanisms of FANCD2 Function
Willers, H., Kachnic, L. A., Luo, C., Li, L., Purschke, M., Borgmann, K., Held, K. D., & Powell, S. N. (2008) · BioMed Research International · doi:10.1155/2008/821529 · Cited by 24
Burkitt, K., & Ljungman, M. E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.017 · Cited by 24
Shima, N., & Pederson, K. D. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.019 · Cited by 26
Dokal, I. S. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200215 · Cited by 24
Lee, K. Y., Chung, K. Y., & Koo, H. (2010) · DNA repair · doi:10.1016/j.dnarep.2009.12.018 · Cited by 24
Brca1 in immunoglobulin gene conversion and somatic hypermutation
Longerich, S., Orelli, B. J., Martin, R. W., Bishop, D. K., & Storb, U. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.10.002 · Cited by 24
Callén, E., Tischkowitz, M. D., Creus, A., Marcos, R., Bueren, J. A., Casado, J. A., Mathew, C. G., & Surrallés, J. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077513 · Cited by 25
Offman, J., Gascoigne, K. E., Bristow, F., Macpherson, P., Bignami, M., Casorelli, I., Leone, G. G. M., Pagano, L., Sica, S., Halil, O., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0182 · Cited by 24
Of mice and (wo)men: genotype-phenotype correlations in BRCA1
Hohenstein, P., & Fodde, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg258 · Cited by 24
Chen, X., Wilson, J. B., McChesney, P. A., Williams, S. A., Kwon, Y., Longerich, S., Marriott, A. S., Sung, P., Jones, N. J., & Kupfer, G. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.552570 · Cited by 24
Leandro, G. D. S., Lôbo, R. R., Oliveira, D. V. N. P., Moriguti, J. C., & Sakamoto‐Hojo, E. T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612380 · Cited by 23
Zhang, L., Chen, H., Gong, M., & Gong, F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00007 · Cited by 24
Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia
Bogliolo, M. (2002) · Mutagenesis · doi:10.1093/mutage/17.1.25 · Cited by 23
Villalona-Calero, M. A., Duan, W., Zhao, W., Shilo, K., Schaaf, L. J., Thurmond, J., Westman, J. A., Marshall, J. L., Li, X., Ji, J. J., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv437 · Cited by 23
Self-citationTurner, J. G., Cui, Y., Bauer, A. A., Dawson, J. L., Gomez, J. A., Kim, J., Cubitt, C. L., Nishihori, T., Dalton, W. S., & Sullivan, D. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0677 · Cited by 23
Wilson, J. B., Blom, E., Cunningham, R., Xiao, Y., Kupfer, G. M., & Jones, N. J. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.04.003 · Cited by 24
D’Andrea, A. D., Dahl, N., Guinan, E. C., & Shimamura, A. (2002) · Hematology · doi:10.1182/asheducation-2002.1.58 · Cited by 24
Self-citationGwon, G. H., Kim, Y., Liu, Y., Watson, A. T., Jo, A., Etheridge, T. J., Yuan, F., Zhang, Y., Kim, Y., Carr, A. M., et al. (2014) · Genes & Development · doi:10.1101/gad.248492.114 · Cited by 23
Bona, N., & Crossan, G. P. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01067-8 · Cited by 23
Yang, H., Zhang, T., Tao, Y., Wu, L., Li, H., Zhou, J., Zhong, C., & Ding, J. (2012) · Structure · doi:10.1016/j.str.2011.12.012 · Cited by 22
Bosch, P. C., Bogliolo, M., & Surrallés, J. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.02.007 · Cited by 22
Yang, Y., Poe, J. C., Yang, L., Fedoriw, A., Desai, S., Magnuson, T., Li, Z., Fedoriw, Y. D., Araki, K., Gao, Y., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw072 · Cited by 23
Taking a Bad Turn: Compromised DNA Damage Response in Leukemia
Nilles, N., & Fahrenkrog, B. (2017) · Cells · doi:10.3390/cells6020011 · Cited by 22
Newell, A. E. H., Hemphill, A., Akkari, Y. M. N., Hejna, J., Moses, R. E., & Olson, S. B. (2008) · Cytogenetic and Genome Research · doi:10.1159/000138882 · Cited by 22
Self-citationThe Fanconi anemia protein interaction network: Casting a wide net
Rego, M. A., Kolling, F. W., & Howlett, N. G. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.018 · Cited by 22
The Fanconi Anemia/BRCA Pathway
Bogliolo, M., & Surrallés, J. (2006) · Springer eBooks · doi:10.1007/0-387-36802-7_6 · Cited by 22
The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage
Dequen, F., St-Laurent, J.-F., Gagnon, S., Carreau, M., & Desnoyers, S. (2005) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2005.05.010 · Cited by 22
FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation
Wang, J., Jo, U., Joo, S. Y., & Kim, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9595 · Cited by 21
Fanconi anemia protein FANCD2 inhibits TRF1 polyADP-ribosylation through tankyrase1-dependent manner
Lyakhovich, A., Ramírez, M. J., Castellanos‐Martín, A., Castellà, M., Simons, A. M., Parvin, J. D., & Surrallés, J. (2011) · Genome Integrity · doi:10.1186/2041-9414-2-4 · Cited by 23
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage
Lee, M. S., Yaar, M., Eller, M. S., Rünger, T. M., Gao, Y. J., & Gilchrest, B. A. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.08.008 · Cited by 21
Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
Wang, Y., Wiltshire, T. D., Senft, J., Wenger, S. L., Reed, E., & Wang, W. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0427 · Cited by 21
Fatal Lymphoproliferative Disease in Two Siblings Lacking Functional FAAP24
Daschkey, S., Bienemann, K., Schuster, V. H., Kreth, H. W., Linka, R. M., Hönscheid, A., Fritz, G., Johannes, C., Fleckenstein, B., Kempkes, B., et al. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0317-y · Cited by 21
Targeting Homologous Recombination Repair in Cancer
Willers, H., Pfäffle, H. N., & Zou, L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384999-1.10007-1 · Cited by 21
Phosphorylation of Fanconi Anemia Protein, FANCA, Is Regulated by Akt Kinase
Otsuki, T., Nagashima, T., Komatsu, N., Kirito, K., Furukawa, Y., Kobayashi, S., Liu, J. M., & Ozawa, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6504 · Cited by 21
Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation
Magdalena, N., Pilonetto, D., Bitencourt, M. A., Pereira, N. F., Ribeiro, R. C., Jeng, M., & Pasqüini, R. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000500003 · Cited by 21
Liang, F., & Jin, F. (2019) · Oncology Letters · doi:10.3892/ol.2019.10046 · Cited by 20
Renaud, E., & Rosselli, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053693 · Cited by 20
Colnaghi, L., Jones, M. V., Cotto-Rios, X. M., Schindler, D., Hanenberg, H., & Huang, T. T. (2010) · Blood · doi:10.1182/blood-2010-07-295758 · Cited by 20
Discrete Nonparametric Algorithms for Outlier Detection with Genomic Data
Ghosh, D. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400903572704 · Cited by 20
Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics
Jenkins, C., Kan, J., & Hoatlin, M. E. (2012) · Anemia · doi:10.1155/2012/481583 · Cited by 20
Activation of the FA pathway mediated by phosphorylation and ubiquitination
Ishiai, M., Sato, K., Tomida, J., Kitao, H., Kurumizaka, H., & Takata, M. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.05.003 · Cited by 20
Evolutionary Clues to the Molecular Function of Fanconi Anemia Genes
Blom, E., van de Vrugt, H. J., de Winter, J. P., Arwert, F., & Joenje, H. (2002) · Acta Haematologica · doi:10.1159/000065659 · Cited by 20
Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg
van de Vrugt, H. J., Koomen, M., Berns, M. A. D., de Vries, Y., Rooimans, M. A., van der Weel, L., Blom, E., de Groot, J., Schepers, R. J., Stone, S., et al. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00518.x · Cited by 20
Fanconi anaemia: from a monogenic disease to sporadic cancer
Valeri, A., Martinez, S. L., Casado, J. A., & Bueren, J. A. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0645-6 · Cited by 19
Geiselhart, A., Lier, A., Walter, D., & Milsom, M. D. (2012) · Anemia · doi:10.1155/2012/265790 · Cited by 19
Su, W., Ho, Y.-C., Wu, C.-K., Hsu, S.-H., Shiu, J.-L., Huang, J.-C., Chang, S., Chiu, W., Hung, J., Liu, T.-L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04223-5 · Cited by 19
Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2
Zahnreich, S., Weber, B., Rösch, G., Schindler, D., & Schmidberger, H. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102992 · Cited by 21
The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target
Sharp, M. F., Bythell‐Douglas, R., Deans, A. J., & Crismani, W. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.023 · Cited by 20
Regulation of the Fanconi Anemia Group C Protein through Proteolytic Modification
Brodeur, I., Goulet, I., Tremblay, C. S., Charbonneau, C., Delisle, M., Godin, C., Huard, C., Khandjian, E. W., Buchwald, M., Lévesque, G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m301291200 · Cited by 19
Hadjur, S., & Jirik, F. R. (2003) · Blood · doi:10.1182/blood-2002-10-3147 · Cited by 19
A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA
Yagasaki, H., Adachi, D., Oda, T., García-Higuera, I., Tetteh, N., D’Andrea, A. D., Futaki, M., Asano, S., & Yamashita, T. (2001) · Blood · doi:10.1182/blood.v98.13.3650 · Cited by 19
Self-citationPeake, J. D., Noguchi, C., Lin, B., Theriault, A., O'Connor, M. H., Sheth, S., Tanaka, K., Nakagawa, H., & Noguchi, E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13072 · Cited by 19
Human LINE-1 retrotransposons: impacts on the genome and regulation by host factors
Luqman-Fatah, A., & Miyoshi, T. (2022) · Genes & Genetic Systems · doi:10.1266/ggs.22-00038 · Cited by 20
The Fanconi anemia pathway: Insights from somatic cell genetics using DT40 cell line
Takata, M., Ishiai, M., & Kitao, H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.012 · Cited by 18
Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage
Zhang, P., Herbig, U., Coffman, F. D., & Lambert, M. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt235 · Cited by 18
Boisvert, R. A., Rego, M. A., Azzinaro, P. A., Mauro, M., & Howlett, N. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081387 · Cited by 18
Xu, D., Dong, L., Guo, Y., & Sun, Y. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.03.044 · Cited by 18
Dicer prevents genome instability in response to replication stress
Fragkos, M., Barra, V., Egger, T., Bordignon, B., Lemacon, D. S., Naim, V., & Coquelle, A. (2019) · Oncotarget · doi:10.18632/oncotarget.27034 · Cited by 18
SCAI promotes error‐free repair of DNA interstrand crosslinks via the Fanconi anemia pathway
Schubert, L. A., Hendriks, I. A., Hertz, E. P. T., Wu, W., Sellés‐Baiget, S., Hoffmann, S., Viswalingam, K. S., Gallina, I., Pentakota, S., Benedict, B., et al. (2022) · EMBO Reports · doi:10.15252/embr.202153639 · Cited by 18
Topo IIIα and BLM Act within the Fanconi Anemia Pathway in Response to DNA-Crosslinking Agents
Hemphill, A., Akkari, Y. M. N., Newell, A. H., Schultz, R. A., Grompe, M., North, P. S., Hickson, I. D., Jakobs, P. M., Rennie, S., Pauw, D., et al. (2009) · Cytogenetic and Genome Research · doi:10.1159/000230001 · Cited by 19
Self-citationZhang, Q., Jun, W., Nguyen, A., Wang, B., He, P., Laurent, G. S., Rennert, O. M., & Su, Y. A. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0231-8 · Cited by 18
Witt, E., & Ashworth, A. (2002) · Science · doi:10.1126/science.1074482 · Cited by 18
The ubiquitin family meets the Fanconi anemia proteins
Renaudin, X., Lerner, L. K., Menck, C. F. M., & Rosselli, F. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.06.004 · Cited by 18
Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair
Kolobynina, K. G., Rapp, A. W., & Cardoso, M. C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.928113 · Cited by 17
FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis
Zhou, H., Wang, Y., Wu, M., Lan, X., Xiang, D., Cai, R., Ma, Q., Miao, J., Fang, X., Wang, J., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6245 · Cited by 17
Particle Beam Radiobiology Status and Challenges: A PTCOG Radiobiology Subcommittee Report
Ahmad, R., Barcellini, A., Baumann, K. S., Benje, M., Bender, T., Bragado, P., Charalampopoulou, A., Chowdhury, R., Davis, A. J., Ebner, D. K., et al. (2024) · International Journal of Particle Therapy · doi:10.1016/j.ijpt.2024.100626 · Cited by 18
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma
Walton, J., Ng, A. S. N., Arevalo, K., Apostoli, A. J., Meens, J., Karamboulas, C., St‐Germain, J. R., Prinos, P., Dmytryshyn, J., Chen, E. X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52507-y · Cited by 17
USP1 in regulation of DNA repair pathways
Aboukheili, A. M. M., & Walden, H. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103807 · Cited by 17
Clark, D. W., Tripathi, K. K., Dorsman, J. C., & Palle, K. (2015) · Oncotarget · doi:10.18632/oncotarget.5006 · Cited by 17
Draga, M., Madgett, E. B., Vandenberg, C. J., du Plessis, D., Kaufmann, A., Werler, P., Chakraborty, P., Lowndes, N. F., & Hiom, K. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01497-14 · Cited by 18
Click, E. S., Cox, B., Olson, S. B., Grompe, M., Akkari, Y. M. N., Moreau, L. A., Shimamura, A., Sternen, D. L., Liu, Y. J., Leppig, K. A., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34024 · Cited by 17
Self-citationFANCD2 is a target for caspase 3 during DNA damage‐induced apoptosis
Sakai, W., & Sugasawa, K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.08.027 · Cited by 17
Kim, S., Hwang, S. K., Lee, M., Kwak, H., Son, K., Yang, J., Kim, S.-H., & Lee, C. H. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.012 · Cited by 17
Metadata
- Authors
- Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D.
- Affiliations
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Hospital for Sick Children (CA)
- Oregon Health & Science University (US)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 7
- Issue
- 2
- Pages
- 249-262
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1991841649
- Cited by
- 1,198
- References
- 71
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 14 · 2023: 20 · 2022: 15 · 2021: 24 · 2020: 25 · 2019: 41 · 2018: 28 · 2017: 20 · 2016: 54 · 2015: 49 · 2014: 51 · 2013: 44 · 2012: 66
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL54785-04, R01HL52725-04, R01HL052725)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043889, R01DK43889-09)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, BRCA1, FANCD2 monoubiquitination, FANCA, FANCC, FANCF, FANCG, DNA repair, radiosensitivity, mitomycin C sensitivity, synaptonemal complex, meiotic chromosomes, nuclear foci, cancer susceptibility
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, DNA-Binding Proteins, Fanconi Anemia, Fluorescent Antibody Technique, Genetic Complementation Test, Humans, Male, Meiosis, Nuclear Proteins, Protein Binding, Proteins, Radiation, Ionizing, Spermatocytes, Synaptonemal Complex, Ubiquitins, Ultraviolet Rays, Mitomycin, Cell Cycle Proteins, BRCA1 Protein, Active Transport, Cell Nucleus, Macromolecular Substances, Mice, Fanconi Anemia Complementation Group Proteins, Fanconi Anemia Complementation Group C Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review